ArticleCancer medicine2021

Marginal improvement in survival among patients diagnosed with metastatic prostate cancer in the second-line antiandrogen therapy era.

Isaac E Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.